Skip to main content
SpringerLink
Log in

Adjuvante Therapie mit einer Echinacea-haltigen Phyto-Kombination bei antibiotikapflichtigen Atemwegsinfektionen

  • Conference paper
Phytopharmaka VII

Zusammenfassung

Die chronische Bronchitis ist eine überwiegend klinisch diagnostizierte Erkrankung, die nach der WHO-Definition mit starkem Husten und mit zunehmend eitriger Sputumproduktion an den meisten Tagen während mindestens 3 Monaten in mindestens 2 aufeinander folgenden Jahren einhergeht. Besonders im fortgeschrittenen Stadium treten durch wiederholte akute Exazerbationen Komplikationen auf, die zu der chronisch obstruktiven Lungenerkrankung (COPD) führen, einer fortschreitenden Erkrankung, die durch eine eingeschränkte, aber über einen längeren Zeitraum relativ stabile Lungenfunktion gekennzeichnet ist [1–4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ball P, Make B (1998) Acute exacerbations of chronic bronchitis. Chest 113(suppl): 199–204

    Article  Google Scholar 

  2. Destache ChJ, Dewan N, O’Donohue WJ, Campbell JC, Angelillo VA (1999) Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis. J Antimicrobial Chemotherapy 43 (suppl A):107–113

    Article  CAS  Google Scholar 

  3. American Thoracic Society (1995) Standards for the diagnosis and care of subjects with chronic obstructive pulmonary disease. Am Rev Respir Dis: 78–83

    Google Scholar 

  4. Grossmann RF (1999) Management of acute exacerbation of chronic bronchitis. Can Respir J 6 (suppl A):40A–45A

    Google Scholar 

  5. Chodosh S (1991) Treatmenty of acute exacerbations of chronic bronchitis: state of the art. Am J Med 91:87–92

    Article  Google Scholar 

  6. Saint S, Bent S, Vittinghof E et al (1995) Antibiotics in chronic obstructive pulmonary disease exacerbations. JAMA 273:957–960

    Article  PubMed  CAS  Google Scholar 

  7. Worth H, Adam D, Handrick W, Leupold W, Lode H, Loos U, Marre R, Mauch H, Schaberg T, Shah P, Sill V, Wettengel R (1997) Prophylaxe und Therapie Von bronchialen Infektionen. Med Klinik 92:699–704

    Article  CAS  Google Scholar 

  8. Wettengel R, Böhning W, Cegla C, Criée C, Fichter J, Geisler L, Fabel H, Köhler D, Konietzko N, Lindemann H, Magnussen H, Matthys H, Meister R, Morr H, Nolte D, Petro W, Schultze-Werninghaus G, Sill V, Sybrecht G, Wiesner B, Worth H (1995) Empfehlungen der Deutschen Atemwegsliga zur Behandlung Von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem. Med Klinik: 3–7

    Google Scholar 

  9. Macfarlane J, Lewis SA, Macfarlane R, Holmes W (1997) Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practice in the U.K.: implications for developing management guidelines. Respiratory Medicine 91:427–434

    Article  PubMed  CAS  Google Scholar 

  10. Tager I, Speizer TE (1975) The role of infection in chronic bronchitis. New Engl J Med 292:563–571

    Article  PubMed  CAS  Google Scholar 

  11. Anthonisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA (1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106:196–204

    PubMed  CAS  Google Scholar 

  12. Eller J, Ede A, Schaberg T, Niedermann MS, Mauch H, Lode H (1998) Infective exacerbations of chronic bronchitis. Chest 113:1542–1548

    Article  PubMed  CAS  Google Scholar 

  13. Anzueto A, Niederman MS, Tillotson GS et al (1998) Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: Ciprofloxacin 750 mg BID versus Clarithromycin 500 mg BID. Clinical Therapeutics 20:885–900

    Article  PubMed  CAS  Google Scholar 

  14. Zuck P, Petitpretz P, Geslin P, Rio Y, Leblanc F (1999) Bacteriological eradication of streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: Cefuroxime Axetil versus Cefixime. IJCP 53:437–443

    PubMed  CAS  Google Scholar 

  15. Chodosh S, McCarty J, Farkas S, Drehobl M, Tosiello R, Shjan M, Aneiro L, Kowalsky St et al (1998) Randomized, double-blind study of Ciprofloxacin and Cefuroxime Axetil for treatment of acute bacterial exacerbations of chronic bronchitis. Clinical Infectious Diseases 27:722–729

    Article  PubMed  CAS  Google Scholar 

  16. Reynolds HY (1995) Chronic bronchitis and acute infectious exacerbations. In: Man-dell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, 4th edn. Churchill Livingstone, New York, pp 608–612

    Google Scholar 

  17. Breiman RF, Butler JC, Tenover FC et al (1994) Emergence of drug-resistant pneumococcal isolates in the United States. JAMA 27:1831–1835

    Article  Google Scholar 

  18. Wüstenberg P, Henneicke-Von Zepelin HH, Köhler G, Stammwitz U (1999) Efficacy and mode of action of an immunomodulator herbal preparation containing Echinacea, Wild Indigo, and White Cedar. Advances in Therapy 16:51–70

    PubMed  Google Scholar 

  19. Bauer R (1996) Echinacea-Drogen-Wirkungen und Wirksubstanzen. Z ärztl Fortbild 90:111–115

    CAS  Google Scholar 

  20. Dorsch W (1996) Klinische Anwendung Von Extrakten aus Echinacea purpurea oder Echinacea pallida. Z ärztl Fortbild 90:117–122

    CAS  Google Scholar 

  21. Melchart D, Linde K, Fischer P, Kaesmayr J (1999) Echinacea for the prevention and treatment of the common cold. The Cochrane Library 1:1–14

    Google Scholar 

  22. Henneicke-Von Zepelin HH, Hentschel C, Schnitker J, Kohnen R, Köhler G, Wüstenberg P (1999) Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study. Current Medical Research Opinion 15:214–227

    Article  CAS  Google Scholar 

  23. Grimm W, Müller HH (1999) A randomized controlled trial of the effect of fluid extract of echinacea purpurea on the incidence and severity of colds and respiratory infections. The American Journal of Medicine 106:138–143

    Article  PubMed  CAS  Google Scholar 

  24. Melchart D, Linde K, Worku F, Sarkady L, Holzmann M, Jurcic K, Wagner H (1995) Results of five randomised studies on the immunomodulatory activity of preparations of echinacea. J Altern Complement Med Summer 1(2):145–160

    Article  CAS  Google Scholar 

  25. Chodosh S, Schreurs A, Siami G, Barkman HW, Anzeto A, Shan M, Moesker H, Stack Th, Kowalsky St et al (1998) Efficacy of oral Ciprofloxacin vs. Clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. Clinical Infectious Diseases 27:730–738

    Article  PubMed  CAS  Google Scholar 

  26. Rocha RT, Awad CE, Ali A, Matyas R, Vital ACC, Silva C, Dainesi SM, Salazar MS, Nakatani J (1999) Comparison of Spiramycin and Clarithromycin for community-acquired lower respiratory tract infections. IJCP 53:433–436

    PubMed  CAS  Google Scholar 

  27. Von Blumröde WO (1985) Angina lacunaris. Eine Untersuchung zum Thema “Steigerung der körpereigenen Abwehr”. Zeitschrift für Allgemeinmedizin 8:271–273

    Google Scholar 

  28. Scaglione F, Henneicke-Von Zepelin HH, Köhler G, Lehmacher W (2002) Prospective, double-blind, placebo-controlled, randomised, clinical dose response study of safety and efficacy of Esberitox® N in the treatment of common cold. Internal clinical study report at Schaper & Brummer (publication in progress)

    Google Scholar 

  29. Zimmer M (1985) Gezielte konservative Therapie der akuten Sinusitis in der HNO-Praxis. Therapiewoche 36:4024–4028

    Google Scholar 

  30. Stolze H, Forth H (1983) Eine Antibiotikabehandlung kann durch zusätzliche Immunstimulierung optimiert werden. Der Kassenarzt 23:43–48

    Google Scholar 

  31. Mador MJ, Rodis A, Ulysses J, Magalang J (1995) Reproducibility of Borg Scale measurements of dyspnea during exercise in patients with COPD. Chest 107:1590–1597

    Article  PubMed  CAS  Google Scholar 

  32. Rychlik R, Pfeil T, Daniel D, Pfeil B, Mast O, Thate-Waschke I, Lorenz J (2001) Zur sozioökonomischen Relevanz akuter Exazerbationen der chronischen Bronchitis in der Bundesrepublik Deutschland. Dtsch Med Wschr 126:353–359

    Article  PubMed  CAS  Google Scholar 

  33. Ball P, Harris JM, Lowson D et al (1995) Acute infective exacerbations of chronic bronchitis. Q J Med 88:61–68

    CAS  Google Scholar 

  34. Shimizu T, Kato M, Mochizuko H, Tokuyama K, Morikawa A, Kuroume T (1994) Roxithromycin reduces the degree of bronchial hyperresponsiveness in children with asthma. Chest 106:548–461

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. EPA Euro Pharma GmbH, Kronberg, Deutschland

    W. Hauke

  2. Schaper & Brümmer, Salzgitter, Deutschland

    G. Köhler

Authors
  1. W. Hauke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Köhler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Schmieder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H.-H. Henneicke-von Zepelin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Freudenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oranienburger Chaussee 25, 13465, Berlin, Deutschland

    Volker Schulz

  2. Am Sellsiekbach 52, 32657, Lemgo, Deutschland

    Norbert Rietbrock

  3. Institut für Klinische Pharmakologie, Universitätsklinikum Charité der Humboldt-Universität zu Berlin Campus Mitte, Schumannstraβe 20/21, 10117, Berlin, Deutschland

    Ivar Roots

  4. Am Allersberg 7, 65191, Wiesbaden, Deutschland

    Dieter Loew

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hauke, W., Köhler, G., Schmieder, G., Zepelin, HH.Hv., Freudenstein, J. (2002). Adjuvante Therapie mit einer Echinacea-haltigen Phyto-Kombination bei antibiotikapflichtigen Atemwegsinfektionen. In: Schulz, V., Rietbrock, N., Roots, I., Loew, D. (eds) Phytopharmaka VII. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57528-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57528-0_4

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-642-63286-0

  • Online ISBN: 978-3-642-57528-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation